T Izzi

468 total citations
24 papers, 305 citations indexed

About

T Izzi is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, T Izzi has authored 24 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Public Health, Environmental and Occupational Health and 8 papers in Genetics. Recurrent topics in T Izzi's work include Acute Lymphoblastic Leukemia research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (6 papers). T Izzi is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (6 papers). T Izzi collaborates with scholars based in Italy and United States. T Izzi's co-authors include Giuseppe Rossi, Giuseppe Lucarelli, Enrico Pogliani, Antonio Porcellini, Renato Bassan, Teresa Lerede, P Polchi, Luciano Moretti, Alessandro Rambaldi and Annunziata Manna and has published in prestigious journals such as Annals of the New York Academy of Sciences, British Journal of Haematology and Leukemia Research.

In The Last Decade

T Izzi

22 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Izzi Italy 11 218 111 78 52 51 24 305
A Chauvenet United States 6 233 1.1× 231 2.1× 39 0.5× 66 1.3× 52 1.0× 9 318
Michael J. Keating United States 9 292 1.3× 103 0.9× 104 1.3× 30 0.6× 96 1.9× 10 400
Saverio Ladogana Italy 13 305 1.4× 187 1.7× 84 1.1× 42 0.8× 94 1.8× 33 432
A Montuoro Italy 8 151 0.7× 60 0.5× 60 0.8× 20 0.4× 71 1.4× 20 215
Lipton Jm United States 6 140 0.6× 121 1.1× 49 0.6× 84 1.6× 28 0.5× 9 320
T Ninomiya Japan 9 213 1.0× 48 0.4× 46 0.6× 52 1.0× 107 2.1× 30 319
Elizabeth M. Alfaro Argentina 10 149 0.7× 148 1.3× 41 0.5× 70 1.3× 44 0.9× 20 277
Karima Yacouben France 7 240 1.1× 85 0.8× 136 1.7× 26 0.5× 42 0.8× 12 341
RB Geller United States 9 301 1.4× 69 0.6× 39 0.5× 23 0.4× 83 1.6× 11 358
Alan W. Lankester United Kingdom 7 332 1.5× 255 2.3× 45 0.6× 79 1.5× 70 1.4× 7 394

Countries citing papers authored by T Izzi

Since Specialization
Citations

This map shows the geographic impact of T Izzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Izzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Izzi more than expected).

Fields of papers citing papers by T Izzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Izzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Izzi. The network helps show where T Izzi may publish in the future.

Co-authorship network of co-authors of T Izzi

This figure shows the co-authorship network connecting the top 25 collaborators of T Izzi. A scholar is included among the top collaborators of T Izzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Izzi. T Izzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Bassan, Renato, Enrico Pogliani, Teresa Lerede, et al.. (1999). Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.. PubMed. 84(12). 1088–93. 13 indexed citations
4.
Bassan, Renato, Teresa Lerede, Eros Di Bona, et al.. (1999). Induction‐consolidation with an idarubicin‐containing regimen, unpurged marrow autograft, and post‐graft chemotherapy in adult acute lymphoblastic leukaemia. British Journal of Haematology. 104(4). 755–762. 15 indexed citations
5.
6.
Alessandrino, Emilio Paolo, C. Astori, MT Van Lint, et al.. (1997). 194 Myelodysplastic syndrome or leukemia developing after MDS treated by allogeneic bone marrow transplantation: Outcome of 90 adult patients. Leukemia Research. 21(1). S52–S52. 3 indexed citations
7.
Bassan, Renato, R Battista, G. Corneo, et al.. (1993). Idarubicin in the Initial Treatment of Adults with Acute Lymphoblastic Leukemia: The Effect of Drug Schedule on Outcome. Leukemia & lymphoma. 11(1-2). 105–110. 16 indexed citations
8.
Rizzoni, Giorgio, et al.. (1992). Late taste disorders in bone marrow transplantation: clinical evaluation with taste solutions in autologous and allogeneic bone marrow recipients.. PubMed. 76(6). 519–22. 21 indexed citations
9.
Casarino, Lucia, et al.. (1992). Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probes.. PubMed. 10(2). 165–70. 10 indexed citations
10.
Guerrasio, Angelo, Giovanni Martinelli, Giuseppe Saglio, et al.. (1992). Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.. PubMed. 6(6). 507–12. 40 indexed citations
11.
Rossi, Giuseppe, P. Marpicati, Fausto Meriggi, et al.. (1991). A phase II trial of promace‐cytabom in previously untreated non‐hodgkin's lymphoma of intermediate‐ or high‐grade histology. Hematological Oncology. 9(3). 147–155. 5 indexed citations
12.
Lucarelli, Giuseppe, P Polchi, T Izzi, et al.. (1985). Marrow Transplantation for Thalassemia after Treatment with Busulfan and Cyclophosphamidea. Annals of the New York Academy of Sciences. 445(1). 428–431. 12 indexed citations
13.
Lucarelli, Giuseppe, P Polchi, T Izzi, et al.. (1984). Allogeneic marrow transplantation for thalassemia.. PubMed. 12(8). 676–81. 45 indexed citations
14.
Izzi, T, P Polchi, M Galimberti, et al.. (1984). Allogeneic bone marrow transplant in acute leukemias and chronic myeloid leukemia. Preliminary results from the BMT center of Pesaro.. PubMed. 69(2). 194–210. 1 indexed citations
15.
Lucarelli, Guido, T Izzi, Adolfo Porcellini, et al.. (1982). Fetal Liver Transplantation in 2 Patients with Acute Leukaemia after Total Body Irradiation. PubMed. 28(1). 65–71. 6 indexed citations
16.
Izzi, T, et al.. (1981). Growth and differentiation patterns of human acute non lymphoid leukemia in diffusion chambers before and after treatment. Annals of Hematology. 43(1). 25–31. 1 indexed citations
17.
Lucarelli, Giuseppe, et al.. (1979). Infusion of Fetal Liver Cells in Aplastic Anemia. Hämatologie und Bluttransfusion. 24. 167–170. 4 indexed citations
18.
Lucarelli, Giuseppe, et al.. (1978). Fetal liver transplantation in severe aplastic anemia.. PubMed. 63(1). 93–4. 2 indexed citations
19.
Izzi, T, et al.. (1978). Antilymphocyte globulin in the treatment of a patient with diffuse proliferative lupus nephritis.. PubMed. 63(6). 689–95. 1 indexed citations
20.
Lucarelli, Giuseppe, Antonio Porcellini, & T Izzi. (1975). [Use of isolators in the treatment of acute leukemias].. PubMed. 66(52). 2612–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Chauvenet Breakdown of academic impact, for papers by Michael J. Keating Breakdown of academic impact, for papers by Saverio Ladogana Breakdown of academic impact, for papers by A Montuoro Breakdown of academic impact, for papers by Lipton Jm Breakdown of academic impact, for papers by T Ninomiya Breakdown of academic impact, for papers by Elizabeth M. Alfaro Breakdown of academic impact, for papers by Karima Yacouben Breakdown of academic impact, for papers by RB Geller Breakdown of academic impact, for papers by Alan W. Lankester
Rankless by CCL
2026